Home > News > PwC expert outlines impact of nanotech, RFID on health care
April 5th, 2006
PwC expert outlines impact of nanotech, RFID on health care
Abstract:
Nanotechnology operates at the atomic or molecular level, and could help to diagnose cancer and other diseases – right when they first occur. Nanotechnology devices could report the onset of cancer at the exact moment of molecular metamorphosis, according to the U.S. National Cancer Institute, and nanoscale devices could enter cells to interact with DNA and proteins, and even monitor cells. At the University of Toronto, research is being done into how nanostructures’ size and morphology are affected by entry into cells.
Source:
itbusiness.ca
Related News Press |
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||